Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07129551) titled 'Navigation, Outcomes and Quality-of-life in Prostate Cancer Patients Undergoing PSMA-targeted Surgery' on Aug. 5.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Martini-Klinik am UKE GmbH
Condition:
Prostate Cancer (Adenocarcinoma)
Intervention:
Procedure: preop virtual 3D model
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: October 2025
Target Sample Size: 102
Countries of Recruitment:
Germany
To know more, visit https://clinicaltrials.gov/ct2/sh...